HilleVax Inc.

NASDAQ: HLVX · Real-Time Price · USD
2.07
-0.01 (-0.48%)
At close: Aug 15, 2025, 3:59 PM
2.08
0.48%
After-hours: Aug 15, 2025, 04:00 PM EDT

HilleVax Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
n/a n/a n/a 2.86M 2.86M 2.86M 2.86M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost of Revenue
n/a 795K 1.5M 2.23M 2.88M 2.5M 1.79M 3.32M 2.67M 2.25M 2.25M 2K 2K 3K 3K 1K 1K n/a
Gross Profit
n/a -795K -1.5M 638K -15K 362K 1.07M -3.32M -2.67M -2.25M -2.25M -2K -2K -3K -3K -1K -1K n/a
Operating Income
-77.12M -104.86M -131.73M -135.87M -143.4M -138.86M -133.34M -116.15M -100.13M -82.76M -65.11M -53.09M -74.87M -63.27M -53.43M -42.8M -3.12M -2.54M
Interest Income
4.48M 5.43M 7.05M 8.44M 8.78M 9.53M 9.71M 8.94M 8.56M 6.44M 3.88M 1.66M 340K 6K n/a 8K 8K 8K
Pretax Income
-71.1M -106.5M -147.27M -150.28M -156.27M -143.51M -123.57M -107.79M -92.78M -118.81M -159.81M -175.95M -221.01M -168.75M -102.41M -65.8M -3.93M -2.94M
Net Income
-71.1M -106.5M -147.27M -150.28M -156.27M -143.51M -123.57M -105.88M -89.58M -156.73M -252.24M -270.29M -316.64M -223.26M -102.41M -65.8M -3.93M -2.94M
Selling & General & Admin
23.44M 25.12M 27.29M 27.64M 28.03M 27.93M 25.94M 25.17M 23.15M 19.9M 16.7M 13.85M 10.39M 7.16M 5.76M 3.51M 2.4M 2.28M
Research & Development
28.9M 54.18M 78.17M 106M 113.14M 109.5M 106.68M 90.98M 76.99M 62.86M 45.91M 36.74M 24.32M 15.96M 10.01M 1.62M 727K 267K
Other Expenses
24.77M 24.77M 24.77M n/a 2.1M 2.42M 2.42M 4.34M 2.21M 1.89M 1.89M -25K n/a n/a n/a n/a n/a n/a
Operating Expenses
77.12M 104.07M 130.23M 133.65M 141.18M 137.43M 132.62M 116.15M 100.13M 82.76M 62.61M 50.6M 34.71M 23.12M 15.77M 5.13M 3.12M 2.54M
Interest Expense
1.85M 2.59M 3.32M 4.04M 2.91M 2.67M 2.39M 1.92M 1.41M 1.8M 3.41M 5.27M 5.78M 4.9M 2.84M 734K 17K 18K
Selling & Marketing Expenses
n/a -795K -1.5M -2.23M -2.23M -1.43M -724K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
77.12M 104.86M 131.73M 135.87M 143.4M 138.86M 133.34M 116.15M 100.13M 82.76M 62.61M 50.6M 34.71M 23.12M 15.77M 5.13M 3.12M 2.54M
Income Tax Expense
n/a n/a n/a n/a n/a n/a n/a -1.91M -3.2M 37.92M 92.43M 94.34M 95.63M 54.52M 17K 17K 17K 9K
Shares Outstanding (Basic)
50.11M 49.98M 49.58M 49.38M 49.18M 48.46M 47.56M 39.04M 37.95M 37.75M 37.66M 37.32M 26.51M 30.19M 30.19M 30.19M 30.19M 30.19M
Shares Outstanding (Diluted)
50.11M 49.98M 49.58M 49.38M 49.18M 48.46M 47.56M 39.04M 37.95M 37.75M 37.66M 37.32M 26.51M 30.19M 30.19M 30.19M 30.19M 30.19M
EPS (Basic)
-1.43 -2.15 -3 -3.1 -3.39 -3.3 -3.04 -2.77 -2.38 -5.23 -8.57 -9.3 -10.93 -7.4 -3.4 -2.18 -0.13 -0.1
EPS (Diluted)
-1.43 -2.15 -3 -3.1 -3.39 -3.3 -3.04 -2.77 -2.38 -5.23 -8.57 -9.3 -10.93 -7.4 -3.4 -2.18 -0.13 -0.1
EBITDA
-66.58M -100.93M -140.75M -143.17M -150.49M -138.33M -119.02M -102.19M -88.34M -114.4M -154.14M -170.68M -156.97M -105.58M -41.3M -6.35M -3.46M -2.47M
EBIT
-69.24M -103.91M -143.95M -146.24M -153.36M -140.84M -121.17M -105.87M -91.37M -117.01M -156.4M -170.68M -215.23M -163.85M -99.56M -65.06M -3.91M -2.91M
Depreciation & Amortization
2.66M 2.98M 3.2M 3.07M 2.88M 2.5M 2.16M 3.68M 3.03M 2.61M 2.25M 4.25K 36.79M 36.79M 38.26M 38.7M 1.91M 1.88M